Thursday, October 23, 2014

Printing with Human Cells

3D Bioprinter by Organovo
3D Bioprinter by Organovo
One of the most important applications for 3D printing is still in the very early stages and is projected to grow to a $6 billion dollar market by the next decade. Bioprinting uses 3D printing technology and bio-ink building blocks to create three dimensional tissue where the cell function and viability are preserved within the printed item.

Cross-section of multi-cellular bioprinted human liver tissue
Cross-section of multi-cellular bioprinted human liver tissue

Using research and patents developed by Dr. Gabor Forgacs at the University of Missouri, Organovo is on the verge of releasing a product that uses 3D bioprinting to create a Human Liver System that can detect toxicity in potential new drugs. By detecting toxicity earlier, the Human Liver System reduces the risks of introducing dangerous drugs and saves the expense of testing in live patients.

While the first applications for Organovo's bioprinting are drug testing, the company believes that "engineered tissues will someday be a routine source of therapy for patients with damages or diseased tissue.  Using bioprinted organ patches made from the patient's own cells could prevent transplant rejection and the need for immunosuppresant drugs.


 
Organovo's scientific founder, Gabor Forgacs, presents on bioprinting at TEDMED.

You might also like: